Navigation Links
Gene Test Could Boost Myeloma Treatment
Date:9/20/2007

Certain DNA influences who'll respond best to therapy, scientists say

THURSDAY, Sept. 20 (HealthDay News) -- Analyzing the activity of a small subset of genes may help identify patients with the worst cases of multiple myeloma, U.S. researchers say.

It may also help guide their treatment, noted the team from the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences.

Multiple myeloma is a cancer that affects the blood plasma cells in bone marrow that produce antibodies. There is wide variation in how well multiple myeloma patients respond to treatment.

This study included 532 patients who were followed for seven years after they had a blood stem cell transplant. The researchers created a genetic profile of each patient to chart the severity of their multiple myeloma.

They found that the activity of as few as 17 genes could determine whether a patient was at high or low risk for a poor prognosis.

The findings were to be presented this week at an American Association for Cancer Research conference in Atlanta.

"There are enormous differences between how different people fare with multiple myeloma. While most do very well, others have a highly aggressive form of the disease, and this is not recognized well with current prognostic variables," lead researcher John D. Shaughnessy Jr., a professor of medicine at the Myeloma Institute for Research and Therapy, said in a prepared statement.

"If we can categorize a patient's risk early, we can better guide that patient toward therapies that might be more effective for them based on the genetic profile of the disease," he explained.

More information

The American Cancer Society has more about multiple myeloma.



-- Robert Preidt



SOURCE: American Association for Cancer Research, news release, Sept. 18, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Lean Protein Could Be Key to Obesity Drugs
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Beware of the oral patch! It could be cancer!!!
5. Low Birth Weight infants could have Problems in the Future
6. False beliefs could cost cancer patients their lives
7. Oxygen Usage During Exercise Could Indicate Heart Problems
8. Prozac miracle could end in disaster
9. Wonder drug - could end in disaster
10. Pollution could be a risk
11. Fright could be more harmful
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing an ... to overcome a rare and deadly chromosome abnormality. , After struggling since birth ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: